Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure. 2010

Michela Cera, and Anna Salerno, and Gabriele Fragasso, and Claudia Montanaro, and Chiara Gardini, and Giovanni Marinosci, and Francesco Arioli, and Roberto Spoladore, and Alberto Facchini, and Cosmo Godino, and Alberto Margonato
Clinical Cardiology-Heart Failure Unit, San Raffaele Scientific Institute, Milan, Italy. michelacera@gmail.com

The aim of the study was to assess whether trimetazidine (TMZ) could affect dispersion of atrial depolarization and ventricular repolarization. Corrected QT interval (QTc), QTc dispersion (QTc-d), Tpeak-Tend, and Tpeak-Tend dispersion (Tpeak-Tend-d) were measured in 30 patients with chronic heart failure (CHF) before and 6 months after randomization to conventional therapy plus TMZ (17 patients) or conventional therapy alone (13 patients). After 6 months, QTc was significantly reduced in both groups, whereas QT-peak was increased only in control group. Tpeak-Tend-d decreased (from 63.53 +/- 24.73 to 42.35 +/- 21.07 milliseconds, P = .006) only in TMZ group. When subgrouped according to CHF etiology, only ischemic patients on TMZ showed Tpeak-Tend-d reduction (65.00 +/- 27.14 vs 36.67 +/- 11.55 milliseconds, P = .001 in ischemic patients; 60.00 +/- 20.00 vs 56.00 +/- 33.86 milliseconds, P = NS, in nonischemic). These electrophysiological properties indicate an undiscovered mechanism of action of TMZ, which could be useful in conditions at risk of major arrhythmias.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000987 Antisocial Personality Disorder A personality disorder whose essential feature is a pervasive pattern of disregard for, and violation of, the rights of others that begins in childhood or early adolescence and continues into adulthood. The individual must be at least age 18 and must have a history of some symptoms of CONDUCT DISORDER before age 15. (From DSM-IV, 1994). Antisocial Behavior,Deviant Behavior,Dyssocial Behavior,Personality Disorder, Antisocial,Psychopathic Personality,Sociopathic Personality,Antisocial Personality,Antisocial Behaviors,Antisocial Personalities,Antisocial Personality Disorders,Behavior, Antisocial,Behavior, Deviant,Behavior, Dyssocial,Behaviors, Antisocial,Behaviors, Deviant,Behaviors, Dyssocial,Deviant Behaviors,Disorder, Antisocial Personality,Disorders, Antisocial Personality,Dyssocial Behaviors,Personalities, Antisocial,Personalities, Psychopathic,Personalities, Sociopathic,Personality Disorders, Antisocial,Personality, Antisocial,Personality, Psychopathic,Personality, Sociopathic,Psychopathic Personalities,Sociopathic Personalities

Related Publications

Michela Cera, and Anna Salerno, and Gabriele Fragasso, and Claudia Montanaro, and Chiara Gardini, and Giovanni Marinosci, and Francesco Arioli, and Roberto Spoladore, and Alberto Facchini, and Cosmo Godino, and Alberto Margonato
January 2014, PloS one,
Michela Cera, and Anna Salerno, and Gabriele Fragasso, and Claudia Montanaro, and Chiara Gardini, and Giovanni Marinosci, and Francesco Arioli, and Roberto Spoladore, and Alberto Facchini, and Cosmo Godino, and Alberto Margonato
January 2002, Kardiologiia,
Michela Cera, and Anna Salerno, and Gabriele Fragasso, and Claudia Montanaro, and Chiara Gardini, and Giovanni Marinosci, and Francesco Arioli, and Roberto Spoladore, and Alberto Facchini, and Cosmo Godino, and Alberto Margonato
October 2010, Circulation journal : official journal of the Japanese Circulation Society,
Michela Cera, and Anna Salerno, and Gabriele Fragasso, and Claudia Montanaro, and Chiara Gardini, and Giovanni Marinosci, and Francesco Arioli, and Roberto Spoladore, and Alberto Facchini, and Cosmo Godino, and Alberto Margonato
August 2009, Arquivos brasileiros de cardiologia,
Michela Cera, and Anna Salerno, and Gabriele Fragasso, and Claudia Montanaro, and Chiara Gardini, and Giovanni Marinosci, and Francesco Arioli, and Roberto Spoladore, and Alberto Facchini, and Cosmo Godino, and Alberto Margonato
August 1983, Surgery,
Michela Cera, and Anna Salerno, and Gabriele Fragasso, and Claudia Montanaro, and Chiara Gardini, and Giovanni Marinosci, and Francesco Arioli, and Roberto Spoladore, and Alberto Facchini, and Cosmo Godino, and Alberto Margonato
December 1987, European heart journal,
Michela Cera, and Anna Salerno, and Gabriele Fragasso, and Claudia Montanaro, and Chiara Gardini, and Giovanni Marinosci, and Francesco Arioli, and Roberto Spoladore, and Alberto Facchini, and Cosmo Godino, and Alberto Margonato
January 2004, Klinicheskaia meditsina,
Michela Cera, and Anna Salerno, and Gabriele Fragasso, and Claudia Montanaro, and Chiara Gardini, and Giovanni Marinosci, and Francesco Arioli, and Roberto Spoladore, and Alberto Facchini, and Cosmo Godino, and Alberto Margonato
March 2012, Journal of the American College of Cardiology,
Michela Cera, and Anna Salerno, and Gabriele Fragasso, and Claudia Montanaro, and Chiara Gardini, and Giovanni Marinosci, and Francesco Arioli, and Roberto Spoladore, and Alberto Facchini, and Cosmo Godino, and Alberto Margonato
May 2001, Heart (British Cardiac Society),
Michela Cera, and Anna Salerno, and Gabriele Fragasso, and Claudia Montanaro, and Chiara Gardini, and Giovanni Marinosci, and Francesco Arioli, and Roberto Spoladore, and Alberto Facchini, and Cosmo Godino, and Alberto Margonato
January 1998, Terapevticheskii arkhiv,
Copied contents to your clipboard!